DiagnosTear Signs Letter of Intent to Advance Commercial Expansion of TeaRx(TM) in India
Vancouver, British Columbia--(Newsfile Corp. - January 22, 2026) - DiagnosTear Technologies Inc. (CSE: DTR) (FSE: X8F) ("DiagnosTear" or the "Company"), an innovator in point-of-care ocular diagnostics, today announced the signing of a Letter of Intent (LOI) with Renovate Biologicals Pvt. Ltd. ("Renovate"), a Hyderabad-based distribution company active in the ophthalmic market, to support the commercial evaluation and potential distribution of TeaRx™
2026-01-22 5:00 PM EST | DiagnosTear Technologies Inc.
FendX and Aquaox Enter into Collaboration Agreement to Pursue Innovation in Eco-Friendly Antimicrobial Agents
Vancouver, British Columbia--(Newsfile Corp. - January 22, 2026) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D0) (the "Company" or "FendX"), an innovative surface protection company developing technology-based solutions to reduce the spread of harmful pathogens, is pleased to announce it has entered into a collaboration agreement (the "Agreement") dated January 20, 2026 with Aquaox LLC ("Aquaox"), a U.S. based manufacturer of environmentally
Technology, Healthcare and Hospitals, Health
2026-01-22 5:00 PM EST | FendX Technologies Inc.
Safe Supply Streaming Co Ltd. Releases Strategic Corporate Update as Commercial Traction, Government Engagement, and Platform Expansion Accelerate
Toronto, Ontario--(Newsfile Corp. - January 22, 2026) - Safe Supply Streaming Co Ltd. (CSE: SPLY) (OTCQB: SSPLF) (FSE: QM4) ("Safe Supply" or the "Company"), a pioneer in health, safety and rapid response technologies, today provided a comprehensive corporate update as the Company enters a new phase of growth marked by commercial execution, government engagement, and strategic brand evolution. Over the past several months, Safe Supply has methodically transitioned f
2026-01-22 7:07 AM EST | Safe Supply Streaming Co Ltd.
Edison Issues Report on Noctiluca (NCL)
London, United Kingdom--(Newsfile Corp. - January 21, 2026) - Edison issues report on Noctiluca (WSE: NCL). Noctiluca is a dynamic advanced materials company specialising in OLED materials for displays and other photonics applications. It has a growing base of engagements with key players globally and is now seeing a significant acceleration driven by the breakthrough performance of its NCEIL-4 material, which has shown a 100% improvement in OLED lifetime across multiple applications. N
Banking / Financial Services, Computer Hardware, Computer Software, Health
2026-01-21 7:29 AM EST | Edison Group
CBIH Evaluates a Potential Reg A Offering of Approximately $1,000,000 to Enable Commercial Launch, Statewide Educational Expansion, and Protection of Its Patent Portfolio
Houston, Texas--(Newsfile Corp. - January 21, 2026) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public company trading on the OTC Markets under the ticker symbol CBIH, announced today that it is in the evaluation stage of a potential financing transaction under Regulation A (Reg A), in an estimated amount in the order of $1,000,000, subject to change, internal review, and applicable market and compliance conditions. CBIH clarifies that this communication reflects
Biotechnology, Pharmaceuticals, Cannabis, Health
2026-01-21 7:00 AM EST | Cannabis Bioscience International Holdings
Defence Therapeutics Sharpens Strategic Focus on Precision Drug Delivery to Unlock the Full Potential of Cancer Biologics
Montreal, Quebec--(Newsfile Corp. - January 21, 2026) - Defence Therapeutics Inc., (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a publicly traded biotechnology company, today announced an evolution of its corporate positioning to reflect its focus as a precision intracellular drug-delivery company advancing its proprietary Accum® platform through both internal development programs and strategic partnerships. Designed to unlock the full potential of comple
Biotechnology, Pharmaceuticals, Health
2026-01-21 3:15 AM EST | Defence Therapeutics Inc.
LevelJump Enters into Cooperation Agreement with Concerned Shareholder; Announces Board Reconstitution
Toronto, Ontario--(Newsfile Corp. - January 20, 2026) - LevelJump Healthcare Corp. (TSXV: JUMP) (OTC Pink: JMPHF) ("LevelJump" or the "Company"), a leading provider of teleradiology and diagnostic imaging services, today announced that it has entered into a cooperation agreement (the "Agreement") with Frank Teti. Under the terms of the Agreement, LevelJump has agreed to a reconstitution of its Board of Directors (the "Board") to include new independent perspectives. Effective imm
Healthcare and Hospitals, Health
2026-01-20 4:00 PM EST | LevelJump Healthcare Corp.
Adia Nutrition Inc. Receives Notification from SEC: Form 10 to Become Effective on February 3, 2026
Winter Park, Florida--(Newsfile Corp. - January 20, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), a leader in regenerative medicine and personalized healthcare, today announced that it has been notified by the U.S. Securities and Exchange Commission (SEC) that its Form 10 registration statement will not be subject to further review. As a result, the Form 10 will automatically become effective 60 days after its original filing date, which is February 3, 2026. The Form 10, originally filed o
Healthcare and Hospitals, Health
2026-01-20 9:30 AM EST | Adia Nutrition Inc.
Phio Pharmaceuticals Announces Key Tumor Response Data from all Cohorts in Intratumoral PH-762 Dose Escalation Cutaneous Carcinoma Trial
King of Prussia, Pennsylvania--(Newsfile Corp. - January 20, 2026) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer. Phio an
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2026-01-20 9:30 AM EST | Phio Pharmaceuticals Corp.
Functional Brands Inc. Introduces Kirkman(R) Detox Aid Bundle: a Comprehensive Approach to Heavy Metal and General Detoxification Support
Lake Oswego, Oregon--(Newsfile Corp. - January 20, 2026) - Functional Brands Inc. (NASDAQ: MEHA), a leading innovator in wellness and performance products, today announced the launch of its Kirkman's Detox Aid bundle, designed to provide foundational support for detoxification-especially targeting heavy metals and environmental toxins. This innovative combination includes Detox Aid with key ingredients such as glutathione, olive leaf, selenium, and alpha-ketoglutarate (AKG), alongside
Household / Consumer / Cosmetics, Health
2026-01-20 8:00 AM EST | Functional Brands Inc.
BioVaxys Reports Positive Clinical Study Results from Phase 1B/2 PESCO Trial of MVP-S with Pembrolizumab (Keytruda (TM)) and Low-Dose Cyclophosphamide for Patients with Recurrent Epithelial Ovarian Cancer (EOC)
Vancouver, British Columbia--(Newsfile Corp. - January 20, 2026) - BioVaxys Technology Corp. (CSE: BIOV) (FSE: 5LB0) (OTCQB: BVAXF) ("BioVaxys" or the "Company"), a clinical stage biotechnology company focused on developing advanced treatments in oncology, in
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2026-01-20 8:00 AM EST | BioVaxys Technology Corp.
Akanda Announces $7.0 Million Convertible Note Offering
Toronto, Ontario--(Newsfile Corp. - January 20, 2026) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company") today announced the execution of a securities purchase agreement with institutional investors for the purchase and sale of 12 month, convertible promissory notes for an aggregate purchase price of $7.0 million, in a private placement transaction. The closing of the transaction is expected to occur, subject to customary closing conditions, on January 21, 2026. The Com
Cannabis, Health, Cannabis Cultivator, Cannabis Manufacturer
2026-01-20 8:00 AM EST | Akanda Corp
Safe Supply Announces Sale of NIRLAB Drug Analysis Device to Far North Resources Inc., Advancing Indigenous-Led Community Safety and Rapid Drug Identification
Toronto, Ontario--(Newsfile Corp. - January 20, 2026) - Safe Supply Streaming Co Ltd. (CSE: SPLY) (OTCQB: SSPLF) (FSE: QM4) ("Safe Supply" or the "Company"), a pioneer in health, safety and rapid response technologies, today announced the sale of a NIRLAB SA ("NIRLAB") NIRLIGHT spectroscopy drug analysis device to Far North Resources Inc., representing the first transaction completed under Safe Supply's exclusive Canadian distribution agreement with NIRLAB, and rei
2026-01-20 7:04 AM EST | Safe Supply Streaming Co Ltd.
Therma Bright Sells an Additional 200-Units of Venowave(TM) to Strategic Distribution Partner Gen-X Med
Toronto, Ontario--(Newsfile Corp. - January 20, 2026) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX0) ("Therma Bright" or the "Company"), a developer and investment partner specializing in advanced diagnostic and medical device technologies, is pleased to announce it has received a follow-on order for an additional 200 Venowave™ VW5 units from its Texas-based distribution partner, Gen-X Med. This latest transaction marks the expansion of the relationship between the
Technology, Biotechnology, Health
2026-01-20 6:30 AM EST | Therma Bright Inc.
Relief AI Assisting World Class Athletes in Mental Preparation For 2026 Olympic Winter Games
Toronto, Ontario--(Newsfile Corp. - January 19, 2026) - Relief AI Inc. (the "Company "or "Relief AI") (www.reliefai.ca), developer of the leading-edge workplace well-being platform naia, which identifies and assists professionals address early signs of workplace burnout, is proud to announce its sponsorship of World Cup Champion and Olympic hopeful Johannes "Hansi" Lochner, Germany's elite bobsleigh athlete. A
Technology, Healthcare and Hospitals, Health
2026-01-19 7:00 AM EST | Relief AI Inc.
DiagnosTear Announces Interim Clinical Results Indicating High Efficiency from TeaRx(TM) Red Eye
Vancouver, British Columbia--(Newsfile Corp. - January 16, 2026) - DiagnosTear Technologies Inc. (CSE: DTR) (FSE: X8F) ("DiagnosTear" or the "Company"), a fast-growing innovator in point-of-care ocular diagnostics, today announced highly encouraging interim results from its ongoing multi-center Israeli clinical study supporting the development of its TeaRx™ Red Eye diagnostic platform. TeaRx™ Red Eye is being developed as the first rapid, multi-biomarker, point-of-car
2026-01-16 7:00 PM EST | DiagnosTear Technologies Inc.
NuGen Medical Devices Provides 2025 Year End Update on R&D and Strategic Progress
Toronto, Ontario--(Newsfile Corp. - January 16, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company"), a leader in needle-free subcutaneous drug-delivery technology, is providing a summary of key developments achieved during 2025 across its Research and Development programs, technical capabilities, clinical initiatives, and global commercial activities. 2025 Operational Highlights Research & Development Demonstrate
Healthcare and Hospitals, Pharmaceuticals, Health
2026-01-16 5:30 PM EST | NuGen Medical Devices Inc.
Hemostemix Receives FDA Support for Its Basket Protocol Approach
Calgary, Alberta--(Newsfile Corp. - January 16, 2026) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0), the leading autologous stem cell company treating those who suffer in pain from peripheral arterial disease, chronic limb threatening ischemia, angina, ischemic cardiomyopathy, dilated cardiomyopathy, and vascular dementia, in Florida, Canada, The Bahamas, announces the successful completion of its pre-Investigational New Drug (pre-IND) meeting with the U.S. Food and Drug Administra
Biotechnology, Pharmaceuticals, Health
2026-01-16 12:26 PM EST | Hemostemix Inc.
LIS Technologies Inc. to Invest $1.38 Billion in Oak Ridge, Tennessee Following Its Acquisition of $8 Million, 206-Acre Duct Island, Now Rebranded as "LIST Island"
Oak Ridge, Tennessee--(Newsfile Corp. - January 16, 2026) - LIS Technologies Inc. ("LIST" or "the Company"), a proprietary developer of advanced laser technology and the only USA-origin and patented laser uranium enrichment company, alongside Tennessee Gov. Bill Lee and Deputy Gov. and Department of Economic and Community Development Commissioner Stuart C. McWhorter, today announced LIST will create 203 jobs and invest $1.38 billion in its future flagship commercial scale laser-
Technology, Mining and Metals, Energy, Health
2026-01-16 10:07 AM EST | LIS Technologies Inc.
Cardiol Therapeutics Announces Bought Deal Financing for Gross Proceeds of $13.5 Million
Toronto, Ontario--(Newsfile Corp. - January 16, 2026) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease, today announced that it has entered into an agreement with a sole underwriter and sole bookrunner pursuant to which the underwriter (the "Underwriter") has agreed to purchase for resale 10,384,616
Biotechnology, Cannabis, Health, Cannabis Manufacturer
2026-01-16 8:46 AM EST | Cardiol Therapeutics Inc.